Sage Journals: Discover world-class research

Abstract

This study investigated household transmission data for influenza (H1N1-2009) in Japan in order to quantify the age-specific risk of infection and estimate the impact of antiviral treatment on the risk of household transmission. Among a total of 1547 households, involving 4609 household contacts, the secondary attack ratio (SAR) was estimated to be 11.4%. School children aged 5 – 18 years dominated the index cases. Age-specific infectiousness and susceptibility were highest among 0 – 4-year olds, with SAR estimated at 19.4% and 29.6%, respectively. Zanamivir treatment within 24 and 24 – 48 h of illness onset in index cases, respectively, reduced the risk of household transmission to 0.57 (95% CI 0.44, 0.73) and 0.58 (95% CI 0.38, 0.86) times that among those receiving the same treatment at > 48 h and those not receiving treatment. The preventive performance of antiviral treatment and prophylaxis should be further examined in randomized controlled trials.

Keywords

Influenza H1N1-2009 Epidemiology Pandemic Antiviral drugs Neuraminidase inhibitors Prophylaxis Oseltamivir Zanamivir

Get full access to this article

View all access options for this article.

References

Fisman

Savage

Gubbay

: Older age and a reduced likelihood of 2009 H1N1 virus infection. N Engl J Med 2009; 361: 2000–2001.

Reichert

Chowell

Nishiura

: Does glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 2010; 10: 5.

Nishiura

Chowell

Safan

: Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009. Theor Biol Med Model 2010; 7: 1.

Nishiura

: Travel and age of influenza A (H1N1) 2009 virus infection. J Travel Med 2010; 17: 269–270.

Nishiura

: Case fatality ratio of pandemic influenza. Lancet Infect Dis 2010; 10: 443–444.

Nishiura

Castillo-Chavez

Safan

: Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill 2009; 14: 19227.

Dawood

Jain

Finelli

: Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605–2615.

Halloran

Struchiner

: Study designs for dependent happenings. Epidemiology 1991; 2: 331–338.

Koopman

Longini

: The ecological effects of individual exposures and nonlinear disease dynamics in populations. Am J Public Health 1994; 84: 836–842.

10.

Cauchemez

Donnelly

Reed

: Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009; 361: 2619–2627.

11.

Halloran

Hayden

Yang

: Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007; 165: 212–221.

12.

Komiya

Kamiya

: Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009. J Infect 2010; 61: 284–288.

13.

Cowling

Fang

: Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 2010; 50: 707–714.

14.

Cowling

Chan

Fang

: Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med 2010; 362: 2175–2184.

15.

Goldstein

Cowling

O'Hagan

: Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis 2010; 10: 211.

16.

Morgan

Parks

Shim

: Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April—May 2009. Emerg Infect Dis 2010; 16: 631–637.

17.

Nishiura

: Household data from the Ugandan hepatitis E virus outbreak indicate the dominance of community infection. Clin Infect Dis 2010; 51: 117–118.

18.

Nishiura

Oshitani

: Effects of vaccination against pandemic (H1N1) 2009 among Japanese children. Emerg Infect Dis 2011; 17: 746–747.

19.

Anonymous: New concerns about oseltamivir. Lancet 2007; 369: 1056.

20.

Halloran

: Secondary attack rate. In: Encyclopedia of Biostatistics. New York: John Wiley and Sons, 1998; pp 4687–4694.

21.

Liang

Zeger

: Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13–22.

22.

Fine

: The interval between successive cases of an infectious disease. Am J Epidemiol 2003; 158: 1039–1047.

23.

Cowling

Fang

Riley

: Estimation of the serial interval of influenza. Epidemiology 2009; 20: 344–347.

24.

Uyeki

: Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009; 361: e110.

25.

Kawai

Ikematsu

Tanaka

: Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007–2008 and 2008–2009 seasons. J Infect Chemother 2010; Dec 1 [epub ahead of print].

26.

Shun-Shin

Thompson

Heneghan

: Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009; 339: b3172.

Household Transmission of Influenza (H1N1-2009) in Japan: Age-Specificity and Reduction of Household Transmission Risk by Zanamivir Treatment

Abstract

Keywords

Get full access to this article

References